Business
Student
- Shop
  Shop all Education Students Discounts Laptops by Major Laptops by Grade Need Help? Find Your PC Student Accessories
- Best Selling Laptops
  ThinkPad X1 Carbon Gen 12 Legion Pro 5i Gaming Yoga 7 2-in-1 IdeaPad Pro 5i Thinkbook 16 Gen 7
Gaming
- Shop Shop All Gaming Gaming Laptops Gaming Desktops Gaming Accessories
  Gaming By Brand
  Lenovo Legion Lenovo LOQ
- Best Selling Legion Pro 5i 16" Legion Tower 7i Legion Go
  Quick Links
  Legion Gaming Community Legion Ultimate Support

My Lenovo Rewards Sale! Save up to {savingPercent} off select items & earn 3X Rewards Sitewide. Ends Thursday! Shop Now >
Shopping for a business? New Lenovo Pro members get $100 off first order of $1,000+, exclusive savings & 1:1 tech support. Learn More >
Buy online, pick up select products at Best Buy. Shop Pick Up >
My Lenovo Rewards! Join for free or sign in to your account and earn 3X Rewards sitewide. That's 9% back! Join For Free >
Business Financing Limited Time Offer! Get 0% interest for 90 days, select Lenovo Financing at checkout. Learn More

Jiangxi Jemincare

Expanding further into the pharmaceutical market.

How Jiangxi Jemincare uses Lenovo ThinkAgile VX to support big data analytics that contributes to smarter decisions and sustainable business growth.

"With the Lenovo platform in place, Jiangxi Jemincare has the infrastructure required to support big data analytics and drive long-term, sustainable growth. The high-performance solution will help the company to gain a deeper view of business performance, identify opportunities, and generate reports faster than ever—enabling leaders to make more effective decisions that minimize risk and increase profitability."

At-a-Glance

Customer: Jiangxi Jemincare
Industry: Healthcare,None
Product Family: lenovo:product-group-and-series/L110056/L210089
Region: China
Processor: Intel
Topic: Hyperconverged Infrastructure

Seizing a greater share of the rapidly expanding pharmaceutical market.

Founded in 1999, Jiangxi Jemincare Group Co. Ltd. develops and manufactures modern Chinese medicines and healthcare products. The company operates research centers and industrial plants in the cities of Jiangxi, Beijing, Shanghai, Jiangsu, and Zhejiang, as well as international drug development teams, and achieves annual revenues of more than US$3.6 billion.

In 2019, the Chinese pharmaceutical sector expanded by almost 9% to become worth US$359 billion; by 2026, analysts believe this figure will almost double to US$650 billion. Jiangxi Jemincare aims to increase its share of this rapidly expanding marketplace and to strengthen its position as one of the ten largest pharmaceutical companies operating in China.